X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (750) 750
Publication (89) 89
Book Review (13) 13
Book Chapter (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (487) 487
teicoplanin (484) 484
pharmacology & pharmacy (334) 334
anti-bacterial agents - pharmacokinetics (254) 254
vancomycin (253) 253
pharmacokinetics (251) 251
male (241) 241
microbiology (229) 229
infectious diseases (216) 216
female (212) 212
teicoplanin - pharmacokinetics (195) 195
anti-bacterial agents - therapeutic use (186) 186
index medicus (183) 183
anti-bacterial agents - administration & dosage (171) 171
adult (167) 167
middle aged (153) 153
anti-bacterial agents - pharmacology (146) 146
teicoplanin - administration & dosage (146) 146
antibiotics (143) 143
microbial sensitivity tests (140) 140
teicoplanin - therapeutic use (137) 137
aged (136) 136
teicoplanin - pharmacology (107) 107
staphylococcal infections - drug therapy (106) 106
animals (102) 102
anti-bacterial agents - blood (98) 98
infections (94) 94
teicoplanin - blood (86) 86
teicoplanin - analogs & derivatives (85) 85
staphylococcus aureus - drug effects (83) 83
glycopeptides - pharmacokinetics (81) 81
resistant staphylococcus-aureus (79) 79
anti-bacterial agents - adverse effects (74) 74
gram-positive bacterial infections - drug therapy (72) 72
efficacy (71) 71
aged, 80 and over (68) 68
therapy (68) 68
vancomycin - pharmacology (68) 68
vancomycin - pharmacokinetics (66) 66
teicoplanin - adverse effects (63) 63
glycopeptides (60) 60
half-life (58) 58
vancomycin - therapeutic use (58) 58
adolescent (57) 57
linezolid (57) 57
treatment outcome (56) 56
gram-positive bacteria (52) 52
serum (52) 52
glycopeptides - therapeutic use (50) 50
methicillin resistance (50) 50
staphylococcal infections - microbiology (50) 50
therapeutic drug monitoring (50) 50
injections, intravenous (49) 49
research article (49) 49
dalbavancin (48) 48
endocarditis (48) 48
staphylococcus-aureus (46) 46
dose-response relationship, drug (43) 43
glycopeptides - administration & dosage (43) 43
glycopeptides - pharmacology (43) 43
bacteremia (42) 42
glycopeptide (42) 42
pharmacology (42) 42
vancomycin - administration & dosage (42) 42
daptomycin (41) 41
infection (41) 41
methicillin-resistant staphylococcus aureus (41) 41
bacterial infections - drug therapy (40) 40
biochemical phenomena, metabolism, and nutrition (40) 40
gram-positive bacteria - drug effects (40) 40
internal medicine (40) 40
drug monitoring (39) 39
staphylococcus aureus (38) 38
child (37) 37
critically-ill patients (37) 37
drug administration schedule (37) 37
in-vitro (37) 37
medicine & public health (37) 37
pharmacodynamics (37) 37
prospective studies (36) 36
rats (36) 36
health aspects (35) 35
methicillin-resistant staphylococcus aureus - drug effects (35) 35
retrospective studies (35) 35
bacteria (34) 34
area under curve (33) 33
infusions, intravenous (32) 32
mrsa (32) 32
drug resistance, bacterial (31) 31
models, biological (31) 31
analysis (30) 30
drug resistance (30) 30
drug therapy (30) 30
glycopeptides - blood (30) 30
gram-positive bacterial infections - microbiology (30) 30
protein binding (30) 30
once-weekly dalbavancin (29) 29
patients (29) 29
resistance (29) 29
antimicrobial agents (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (662) 662
French (34) 34
Japanese (32) 32
Spanish (18) 18
German (5) 5
Italian (3) 3
Russian (3) 3
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181090
Platelet rich fibrin (PRF) is an autologous fibrin glue, produced from patients' blood, which, besides intraoperative use, has applications in the treatment of... 
Biguanides - pharmacology | Platelet-Rich Plasma - chemistry | Klebsiella pneumoniae - drug effects | Bandages | Amikacin - pharmacokinetics | Agar - chemistry | Humans | Pseudomonas aeruginosa - growth & development | Delayed-Action Preparations - pharmacology | Delayed-Action Preparations - pharmacokinetics | Teicoplanin - pharmacology | Teicoplanin - pharmacokinetics | Wound Healing - drug effects | Methicillin-Resistant Staphylococcus aureus - drug effects | Fibrin - pharmacology | Platelet-Derived Growth Factor - pharmacology | Pseudomonas aeruginosa - drug effects | Amikacin - pharmacology | Biguanides - pharmacokinetics | Methicillin-Resistant Staphylococcus aureus - growth & development | Models, Biological | Anti-Bacterial Agents - pharmacokinetics | Disk Diffusion Antimicrobial Tests | Drug Liberation | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Care and treatment | Usage | Amikacin | Research | Pharmacokinetics | Wounds and injuries | Platelet-rich plasma therapy | Antiinfectives and antibacterials | Teicoplanin | Blood platelets | Leg ulcers | Bacteria | Silicon | Inhibition | Growth factors | Wound healing | Wounds | Agar | Staphylococcus infections | Antimicrobial agents | Pharmacology | Patients | Polyhexanide | Gauze | Medicine | Fibrin | Interpolation | Infectious diseases | Antibiotics | Minimum inhibitory concentration | Kinetics | Platelets
Journal Article
Archives of Disease in Childhood, ISSN 0003-9888, 06/2019, Volume 104, Issue 6, pp. e35 - e35
BackgroundPharmacokinetics (PK) are severely altered in critically ill patients due to changes in volume of distribution (Vd) and/or drug clearance (Cl). To... 
Neonates | Amikacin | Cefotaxime | Gentamicin | Daptomycin | Vancomycin | Ceftriaxone | Teicoplanin | Cephalosporins | Antibiotics | Piperacillin | Amoxicillin | Penicillin | Children | Metronidazole | Pharmacokinetics | Carbapenems | Drug dosages | Ceftazidime
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2017, Volume 61, Issue 9
The pharmacokinetics (PK) of drugs are known to be significantly altered in patients receiving extracorporeal membrane oxygenation (ECMO). However, clinical... 
Population pharmacokinetics | Extracorporeal membrane oxygenation | Pharmacokinetics | Cardiogenic shock | Teicoplanin | teicoplanin | ADULTS | MICROBIOLOGY | cardiogenic shock | CRITICALLY-ILL | NOSOCOMIAL INFECTIONS | population pharmacokinetics | CHILDREN | SUPPORT | VANCOMYCIN | THERAPY | INFANTS | pharmacokinetics | PHARMACOLOGY & PHARMACY | extracorporeal membrane oxygenation | NONMEM
Journal Article
Journal Article
Breastfeeding Medicine, ISSN 1556-8253, 05/2017, Volume 12, Issue 4, pp. 244 - 246
Pharmacokinetics of teicoplanin in a breastfeeding mother 
Correspondence | PEDIATRICS | OBSTETRICS & GYNECOLOGY | Female | Anti-Bacterial Agents | Mothers | Humans | Teicoplanin | Breast Feeding | Index Medicus | Life Sciences
Journal Article
Infectious Diseases, ISSN 2374-4235, 07/2017, Volume 49, Issue 7, pp. 483 - 492
Journal Article
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 2019
Teicoplanin is an antibiotic agent used for the treatment of Gram-positive infections. The clinical benefit of teicoplanin is associated with its blood... 
teicoplanin | pharmacokinetics | C-reactive protein | pharmacodynamics | therapeutic drug monitoring
Journal Article